date,title,source
Nov-01-18,"Magenta Therapeutics Announces Acceptance of Nine Abstracts Covering Clinical and Preclinical Data at ASH, Representing Progress across the Portfolio of Conditioning, Stem Cell Mobilization and Expansion Programs",Business Wire
Nov-08-18,Magenta Therapeutics Reports Recent Operational Progress and Third Quarter 2018 Financial Results,Business Wire
Nov-19-18,Magenta Therapeutics Appoints Jason Ryan as Chief Operating and Financial Officer,Business Wire
